In this episode of the AusCannaPodcast, I sit down with Michael Sassano, CEO and Chairman of SOMAI Pharmaceuticals, to explore the cutting-edge innovations driving the pharmaceutical cannabis industry. Michael shares insights on SOMAI’s state-of-the-art EU-GMP facility, the company’s sustainable production practices, and the exciting opportunities in emerging markets like Germany, Spain, and Australia.
From overcoming industry challenges to envisioning the global future of medical cannabis, Michael offers a wealth of knowledge, passion, and inspiration. Whether you’re a cannabis advocate, an industry insider, or simply curious, this episode is packed with valuable takeaways.
In this episode, we cover a lot of topics including:
Rapid Fire
Who is Michael Sassano
What drew Michael into the industry
SOMAI’s vision from the start
Michael’s thoughts on cannabis legalization in the USA
SOMAI’s extraction programs… Nano emulsions come back?
The lack of education and research on medical cannabis
Challenges in balancing compliance and innovation in a tightly regulated industry
The rapidly growing global medical cannabis industry
What’s special about Germany
What’s the medical cannabis scene like in Portugal
Misconceptions encountered in the pharmaceutical cannabis industry
If global legalization happened overnight would that change SOMAI’s trajectory
SOMAI’s cultivation vision
Equal flower love for everyone
Extraction vs Cultivation setups
Plants are like children
SOMAI Pharmaceuticals’s long-term vision in terms of innovation and market reach
What country could be the next to embrace medical cannabis?
Will we ever have a cannabis impairment test?
Where will the global cannabis industry be in 10 years, and what role will SOMAI play in shaping that future?
Michael’s call to action
Show Notes:
Where to find Michael:
Where to find me:
Share this post